{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:20:15Z","timestamp":1779913215177,"version":"3.53.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1992,5,1]],"date-time":"1992-05-01T00:00:00Z","timestamp":704678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[1992,5]]},"DOI":"10.1007\/bf00145362","type":"journal-article","created":{"date-parts":[[2004,11,6]],"date-time":"2004-11-06T11:10:06Z","timestamp":1099739406000},"page":"120-124","source":"Crossref","is-referenced-by-count":6,"title":["Activity profile of gemfibrozil on the major plasma lipoprotein parameters"],"prefix":"10.1007","volume":"8","author":[{"given":"C. R.","family":"Sirtori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gianfranceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Maderna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0021-9150(90)90006-5","volume":"84","author":"L. Calabresi","year":"1990","unstructured":"CalabresiL.,FranceschiniG.,SirtoriM.,GianfranceschiG.,WerbaP. andSirtoriC.R. (1990): Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease - Atherosclerosis84: 41?48.","journal-title":"Atherosclerosis"},{"issue":"2","key":"CR2","first-page":"49","volume":"69","author":"A. Eisalo","year":"1976","unstructured":"EisaloA. andManninenY. (1976): A long term trial of gemfibrozil in the treatment of hyperlipidaemias -Proc. R. Soc. Med.69 (Suppl. 2): 49?52.","journal-title":"Proc. R. Soc. Med."},{"key":"CR3","first-page":"240","volume":"114","author":"G. Franceschini","year":"1989","unstructured":"FranceschiniG.,SirtoriM.,YaccarinoV.,GianfranceschiG.,ChiesaG. andSirtoriC.R. (1989): Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia - J. Lab. Clin. Med.114: 240?259.","journal-title":"J. Lab. Clin. Med."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","volume":"316","author":"M.H. Frick","year":"1987","unstructured":"FrickM.H.,EloO.,HaapaK.,HeinonenP.P.,HeinsalmiO.,HeloP.,HuttunenJ.K.,KaitaniemiP.,KoshinenP.,ManninenY.,MaenpaaH.,MalkonenM.,ManttariM.,NorolaS.,PasternackA.,PikkarainenJ.,RomoM.,SjoblomT. andNikkil\u00e4E. (1987): Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dislypidemia - N. Engl. J. Med.316: 1237?1245.","journal-title":"N. Engl. J. Med."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM198807073190105","volume":"319","author":"S.M. Grundy","year":"1988","unstructured":"GrundyS.M. (1988): HMG CoA reductase inhibitors for treatment of hypercholesterolemia - N. Engl. J. Med.319: 24?33.","journal-title":"N. Engl. J. Med."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI111892","volume":"75","author":"Y. Kleinman","year":"1985","unstructured":"KleinmanY.,EisenbergS.,OschryY.,GavishD.,SteinO. andSteinY. (1985): Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts - J. Clin. Invest.75: 1796?1803.","journal-title":"J. Clin. Invest."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/clpt.1988.36","volume":"43","author":"K. Laustiola","year":"1988","unstructured":"LaustiolaK.,LassilaR.,KoskinenP.,PellinenT. andManninenY. (1988): Gemfibrozil decreases platelet reactivity in patients with hypercholesterolemia during physical stress - Clin. Pharmacol. Ther.43: 302?307.","journal-title":"Clin. Pharmacol. Ther."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0021-9150(77)90124-1","volume":"26","author":"R. Pichardo","year":"1977","unstructured":"PichardoR.,BouletL. andDavignonJ. (1977): Pharmacokinetics of clofibrate in familial hypercholesterolemia - Atherosclerosis 26: 573?582.","journal-title":"Atherosclerosis"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(81)92534-4","volume":"i","author":"C.R. Sirtori","year":"1981","unstructured":"SirtoriC.R. (1981): Mechanism of action of clofibrate - Lanceti; 1362.","journal-title":"Lancet"},{"key":"CR10","first-page":"279","volume":"110","author":"C.R. Sirtori","year":"1987","unstructured":"SirtoriC.R.,FranceschiniG.,GianfranceschiG.,SirtoriM.,MontanariG.,TremoliE.,MadernaP.,ColliS. andZoppiF. (1987): Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia - J. Lab. Clin. Med.110: 279?286.","journal-title":"J. Lab. Clin. Med."},{"key":"CR11","doi-asserted-by":"crossref","unstructured":"Tikkanen M.J., Helve E., Jaattela A., Kaarsalo E., Lehtonen A., Malbecq W., Oksa H., Paakkonen P., Salmi J., Veharanta T. andAarynen M. (1988): Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The Finnish Multicenter Study - Am. J. Cardiol.62: 35J-43J.","DOI":"10.1016\/0002-9149(88)90005-7"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00145362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00145362\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00145362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T06:01:26Z","timestamp":1554271286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00145362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":11,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1992,5]]}},"alternative-id":["BF00145362"],"URL":"https:\/\/doi.org\/10.1007\/bf00145362","relation":{},"ISSN":["0392-2990","1573-7284"],"issn-type":[{"value":"0392-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5]]}}}